Does RUXOLITINIB Cause Dermatitis atopic? 211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Dermatitis atopic have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.3% of all adverse event reports for RUXOLITINIB.
211
Reports of Dermatitis atopic with RUXOLITINIB
0.3%
of all RUXOLITINIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Dermatitis atopic From RUXOLITINIB?
Of the 211 reports, 10 (4.7%) required hospitalization.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
ADALIMUMAB (103)
Which RUXOLITINIB Alternatives Have Lower Dermatitis atopic Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE